MEF2 is upregulated during cardiac hypertrophy and is required for normal post-natal growth of the myocardium (Q28506129)

24 January 2017

title

MEF2 is upregulated during cardiac hypertrophy and is required for normal post-natal growth of the myocardium (English)

1 reference

Myocyte enhancer factor 2C

24 January 2017

0 references

1 reference

GOA release 2020-03-11

0 references

S. M. Kolodziejczyk

1

1 reference

24 January 2017

L. Wang

2

1 reference

24 January 2017

K. Balazsi

3

1 reference

24 January 2017

Y. DeRepentigny

4

1 reference

24 January 2017

R. Kothary

5

1 reference

24 January 2017

L. A. Megeney

6

1 reference

24 January 2017

language of work or name

English

0 references

publication date

21 October 1999

1 reference

24 January 2017

1 reference

24 January 2017

volume

9

1 reference

24 January 2017

issue

20

1 reference

24 January 2017

page(s)

1203–1206

1 reference

DNA synthesis in rat heart cells after injury and the regeneration of myocardia

24 January 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2800%2980027-5

7 January 2021

Control of cardiac muscle cell division

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2800%2980027-5

7 January 2021

Human fetal heart development after mid-term: morphometry and ultrastructural study

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2800%2980027-5

7 January 2021

Rapid transition of cardiac myocytes from hyperplasia to hypertrophy during postnatal development

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2800%2980027-5

7 January 2021

The cardiomyopathy of overload: an unnatural growth response

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2800%2980027-5

7 January 2021

Contractile protein mutations and heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2800%2980027-5

7 January 2021

Familial hypertrophic cardiomyopathy: from mutations to functional defects

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2800%2980027-5

7 January 2021

Postnatal growth of the heart and its blood vessels

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2800%2980027-5

7 January 2021

Transcriptional regulation during cardiac growth and development

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2800%2980027-5

7 January 2021

The cellular and molecular response of cardiac myocytes to mechanical stress.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2800%2980027-5

7 January 2021

A calcineurin-dependent transcriptional pathway for cardiac hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2800%2980027-5

7 January 2021

Prevention of Cardiac Hypertrophy in Mice by Calcineurin Inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2800%2980027-5

7 January 2021

Calcineurin inhibitors and cardiac hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2800%2980027-5

7 January 2021

Transient cardiac expression of constitutively active Galphaq leads to hypertrophy and dilated cardiomyopathy by calcineurin-dependent and independent pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2800%2980027-5

7 January 2021

Severe cardiomyopathy in mice lacking dystrophin and MyoD

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2800%2980027-5

7 January 2021

A role for the p38 mitogen-activated protein kinase pathway in myocardial cell growth, sarcomeric organization, and cardiac-specific gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2800%2980027-5

7 January 2021

Opposing effects of Jun kinase and p38 mitogen-activated protein kinases on cardiomyocyte hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2800%2980027-5

7 January 2021

Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2800%2980027-5

7 January 2021

Murine pulmonary myocardium: developmental analysis of cardiac gene expression.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2800%2980027-5

7 January 2021

Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2800%2980027-5

7 January 2021

Regulation of the MEF2 family of transcription factors by p38

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2800%2980027-5

7 January 2021

A dominant-negative form of transcription factor MEF2 inhibits myogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2800%2980027-5

7 January 2021

Post-translational control of the MEF2A transcriptional regulatory protein

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2800%2980027-5

7 January 2021

Molecular pathways controlling heart development

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2800%2980027-5

7 January 2021

Ablation of the murine alpha myosin heavy chain gene leads to dosage effects and functional deficits in the heart

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2800%2980027-5

7 January 2021

The beta-globin locus control region enhances transcription of but does not confer position-independent expression onto the lacZ gene in transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2800%2980027-5

7 January 2021

10.1016/S0960-9822(00)80027-5

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017